| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3B | $7.4B | $6.1B | $6.2B | $5.9B | $5.6B | $4.3B | $4.3B |
| Cost of Revenue | $3.0B | $2.8B | $2.2B | $2.6B | $2.5B | $2.7B | $1.7B | $1.8B |
| Gross Profit | $5.2B | $4.6B | $3.9B | $3.6B | $3.4B | $2.9B | $2.5B | $2.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.3B | $1.8B | $1.6B | $1.6B | $1.4B | $1.2B | $1.0B | $1.0B |
| Net Income | $1.8B | $1.1B | $1.1B | $1.1B | $1.2B | $0.9B | $0.8B | $0.5B |
| EPS (Basic) | $3.12 | $1.94 | $2.10 | $2.28 | $7.15 | $5.67 | $4.69 | $2.77 |
| EPS (Diluted) | $3.09 | $1.93 | $2.08 | $2.26 | $7.05 | $5.59 | $4.63 | $2.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.1B | $30.4B | $32.3B | $20.9B | $20.1B | $18.0B | $13.9B | $15.7B |
| Current Assets | $8.0B | $7.8B | $9.1B | $8.6B | $7.4B | $7.7B | $4.3B | $6.4B |
| Cash & Equivalents | $0.6B | $0.6B | $0.5B | $0.5B | $0.4B | $2.7B | $0.3B | $0.5B |
| Total Liabilities | $18.8B | $19.2B | $21.5B | $14.7B | $13.7B | $11.5B | $8.3B | $10.3B |
| Current Liabilities | $8.0B | $7.9B | $9.0B | $8.8B | $7.9B | $4.9B | $4.2B | $6.6B |
| Stockholders' Equity | $12.2B | $11.2B | $10.8B | $6.2B | $6.4B | $6.4B | $5.6B | $5.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $1.9B | $1.7B | $1.7B | $1.1B | $1.3B | $1.0B | $1.0B |
| Investing Cash Flow | $-1.1B | $-1.0B | $-6.0B | $0.0B | $-2.7B | $-0.2B | $-0.2B | $0.2B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $-3.0B | $-2.6B | $4.2B | $1.0B | $1.4B | $1.4B | $-0.9B | $-1.0B |